Page 45 - Glucose Monitoring Devices
P. 45

References     41




                  [16] U.S. Department of Health and Human Services, U.S. Food and Drug Administration,
                      Statement from FDA Commissioner, Gottlieb S, Shuren J. Director of the center for de-
                      vices and radiological health, on FDA’s updates to medical device safety action plan to
                      enhance post-market safety. 2018. Available from: https://www.fda.gov/NewsEvents/
                      Newsroom/PressAnnouncements/ucm626286.htm. [Accessed 30 December 2018].
                  [17] Pfutzner A. Advances in patient self-monitoring of blood glucose. Journal of Diabetes
                      Science and Technology 2016;10:101e3.
                  [18] Baumstark A, Schmid C, Pleus S, et al. Influence of partial pressure of oxygen in blood
                      samples on measurement performance in glucose-oxidase-based systems for self- moni-
                      toring of blood glucose. Journal of Diabetes Science and Technology 2013;7:1513e21.
                  [19] U.S. Department of Health and Human Services, Office of Inspector General. Medicare
                      market shares of mail-order diabetes test strips from October through December 2016.
                      2017. Available from: https://oig.hhs.gov/oei/reports/oei-04-16-00473.pdf. [Accessed
                      23 November 2018].
   40   41   42   43   44   45   46   47   48   49   50